POLYNOVO LIMITED

ASX:PNVHealth Care Equipment & Services

690.8M shares on issueASX (delayed) · snapshot 11 Sept 2026701.4M fully diluted+1.5% if every option and right converts$1.00price · delayed$690.8Mmarket cap · indicative

Today’s holders own 98.5% of what they think they own, once every option and right converts.

Minimal

Dilution risk

No major dilution pressure signals in current disclosures

Absolute levels — not a ranking against other companies.

Cash runwayno data — not a quarterly (4C/5B) cash filer

Share-count growth (24m)0.0%

Raise cadence (24m)0 cash raises

Options & rights overhang1.5% of shares

In-the-money supplyno data — no exercise price on record

Pending proposed issuesnone

POLYNOVO LIMITED's ordinary share count stood at 691M as of November 2024, unchanged from August 2024. The company has not undertaken any capital raises in the past 24 months and has no pending proposed securities issues. Options and rights on issue could convert into 11M new shares, representing 1.5% of the current share count, with none currently in the money; no expiry date for these securities has been filed. POLYNOVO LIMITED has not lodged a current quarterly cash report, so no available cash or funding-runway figure is disclosed on that basis.

AI-generated summary of this page's cited filings · updated 11 Sept 2026

Get told when this changes

Set up alerts

Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.

1.5%

Options & rights overhang

—

In-the-money supply · no stated strikes

Raises · last 12 months

—

Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue

Weekly counts from ASX records. Dots mark cash capital raises. Latest count 690.8M per ASX (delayed) (snapshot 11 Sept 2026).

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

Date	Form	Security	On issue, per this filing	Source
28 Nov 2024	2A · quoted issue	PNV : ORDINARY FULLY PAID	690.8M	Appendix 2A
28 Nov 2024	3G · unquoted	ORDINARY FULLY PAID	690.8M	Appendix 3G
28 Nov 2024	3H · cancellation	PNV : ORDINARY FULLY PAID	690.8M	Appendix 3H
4 Oct 2024	2A · quoted issue	PNV : ORDINARY FULLY PAID	690.8M	Appendix 2A
23 Aug 2024	3G · unquoted	ORDINARY FULLY PAID	690.2M	Appendix 3G

Free account

7 filings on record — Full issuance history

Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Capital raises

No equity raises in the last 24 months.

Free account

Full raise history

Issue price, shares issued, brokers and stated purpose for every raise on record.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account

Forward supply calendar

Option expiries and proposed issues on one forward timeline, with the securities each could add.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

No Appendix 3B in the last 12 months reports an issue under the 15% placement capacity (as at 2026-09-12).

Free account

Placement capacity — LR 7.1 / 7.1A

The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

1.5%

Options & rights overhang · of current shares

—

In-the-money supply · no stated strikes

10.5M

Potential new shares

—

Nearest expiry

What a price move would switch on

No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 10.5M of it converts on something else — a hurdle that may never be met, or terms the filing does not price.

Code	Security	Type	Exercise price	Expiry	On issue	Source
PNVAA	Options	Price-triggered	—	—	10.5M	Filing

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.

Free account

1 option line on record — In-the-money value & price ladder

What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.

Free account: 2 full company unlocks every month, no card.

Create free account See plans

Director dealings

Date	Director	Type	Shares	Options	Other	Value	Source
12 Mar 2026	Mr Robert Douglas	Buy on-market	151k	—	—	$100k	3Y notice
25 Feb 2026	Leon Hoare	Buy on-market	30k	—	—	$28k	3Y notice
24 Feb 2026	Mr Andrew Lumsden	Buy on-market	100k	—	—	$91k	3Y notice